-
Dec 11, 2024 | 
labpulse.com | Liz Carey |Matt Limb |Nick Paul Taylor |Elissa Wolfson
While the method of cervical cancer screening is beginning to change worldwide,human papillomavirus (HPV) tests, Papanicolaou (Pap) tests, and co-testing are all effective and recommended by the U.S. Preventive Services Task Force (USPSTF), according to newly drafted cervical cancer screening guidelines published December 10.
-
Dec 10, 2024 | 
labpulse.com | Nick Paul Taylor |Elissa Wolfson |Melissa Busch |Brian Casey
Research sparked by the growing trend of using multiplex molecular syndromic panels to diagnose urinary tract infection (UTI) in older adults suggests the tests may be causing clinical harm through misdiagnosis and unnecessary antibiotics, in addition to draining Medicare money, according to original research published in JAMA Network Open.
-
Nov 27, 2024 | 
labpulse.com | Nick Paul Taylor |Elissa Wolfson |Melissa Busch |Brian Casey
The Canadian Food Inspection Agency (CFIA) signaled laboratory error, cross-contamination with the positive control strain of a harmful bacteria, when it rescinded a recall of a food product feared to be tainted with Salmonella, the U.S. Food and Drug Administration (FDA) explained this week. Following the positive Salmonella laboratory testing result, the CFIA completed a whole genome sequencing (WGS) analysis of the Salmonella isolate, the FDA said.
-
Nov 7, 2024 | 
labpulse.com | Matt Limb |Nick Paul Taylor |Elissa Wolfson
Meridian Bioscience took first place among three phase II winners in the U.S. Centers for Disease Control and Prevention's (CDC) Lead Detect Prize competition. The competition is aimed at advancing the development of rapid point-of-care (POC) blood lead-testing technology.
-
Nov 5, 2024 | 
labpulse.com | Nick Paul Taylor |Matt Limb |Elissa Wolfson
Digital pathology firm Inify Laboratories is collaborating with scientists at the Karolinska Institutet in Stockholm on a project aimed at improving the precision of prostate cancer diagnosis through artificial intelligence (AI)-driven image analysis. In a statement, Inify said it will work with the multidisciplinary ProMort research team at the Karolinska Institutet on the endeavor.
-
Nov 1, 2024 | 
labpulse.com | Liz Carey |Matt Limb |Elissa Wolfson |Leah Sherwood
Biotech firm Sunbird Bio announced new data from a study demonstrating that Sunbird's technology could provide blood-based diagnosis of Parkinson's disease and other neurodegenerative diseases with a high level of accuracy. The results were shared on October 31 in a poster presentation at the Clinical Trials on Alzheimer's Disease 2024 international conference in Madrid, the company said in a statement.
-
Sep 20, 2024 | 
labpulse.com | Matt Limb |Nick Paul Taylor |Elissa Wolfson |Joseph Constance
As clinical laboratory testing sheds light on the effects of popular new drugs such as Ozempic and Wegovy, biomarker testing and tissue imaging are already revealing how the drugs change body composition. Researchers at the University of Wisconsin in Madison looked deeper than weight and waist circumference to focus on certain biomarker measures related to cardiometabolic risk.
-
Sep 17, 2024 | 
labpulse.com | Nick Paul Taylor |Elissa Wolfson |Leo O'Connor
On the heels of monkeypox, avian or bird flu has become a hot focus of the U.S. Centers for Disease Control and Prevention (CDC)'s new contracts with a handful of commercial reference laboratories in the U.S. Utah-based ARUP Laboratories announced on September 13 its selection as a partner in the development of an avian influenza A (H5N1) test. Tennessee-based Aegis Sciences, Boston-based Ginkgo Bioworks, Labcorp, and Quest Diagnostics were also named.
-
Sep 4, 2024 | 
labpulse.com | Nick Paul Taylor |Elissa Wolfson
The Association for Diagnostics and Laboratory Medicine (ADLM, formerly AACC) has published guidance for standardizing lipid testing, reporting, and interpretation. Published September 3 in The Journal of Applied Laboratory Medicine, the recommendations are important for clinicians and clinical laboratory professionals in the management of atherosclerotic cardiovascular disease (ASCVD) risk through lipid assessment.
-
Aug 28, 2024 | 
labpulse.com | Matt Limb |Nick Paul Taylor |Elissa Wolfson
Experts plan to update and extend the 2013 and 2018 practice guidelines that established evidence-based best practices for molecular biomarker testing for patients diagnosed with lung adenocarcinoma, according to the three organizations sponsoring the project. The College of American Pathologists (CAP), International Association for the Study of Lung Cancer (IASLC), and Association for Molecular Pathology (AMP) will take comments from key stakeholders until September 12, 2024.
